Dr. W. Kimryn Rathmell\u2019in The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute\u2019nin (OSUCCC \u2013 James) yeni CEO\u2019su olarak atanmas\u0131, kanser ara\u015ft\u0131rmalar\u0131 ve klinik bak\u0131m alan\u0131nda \u00f6nemli bir d\u00f6nemin ba\u015flang\u0131c\u0131n\u0131 m\u00fcjdeliyor. May\u0131s 2025\u2019te resmi onay\u0131n ard\u0131ndan g\u00f6revine ba\u015flayacak olan Dr. Rathmell, molek\u00fcler biyoloji, onkoloji ve sa\u011fl\u0131k e\u015fitli\u011fi kesi\u015fiminde kazand\u0131\u011f\u0131 tecr\u00fcbelerle Ohio State\u2019in \u00f6nde gelen kanser merkezini d\u00f6n\u00fc\u015ft\u00fcrmeyi hedefliyor. Bu atama, birinci s\u0131n\u0131f ara\u015ft\u0131rmalar ile hasta merkezli yenili\u011fi birle\u015ftirerek sa\u011fl\u0131k hizmetlerinde yeni bir \u00e7\u0131\u011f\u0131r a\u00e7mak ad\u0131na stratejik bir hamle olarak de\u011ferlendiriliyor.<\/p>\n
Dr. Rathmell, Aral\u0131k 2023\u2019ten Ocak 2025\u2019e kadar ABD Ulusal Kanser Enstit\u00fcs\u00fc\u2019n\u00fcn (NCI) 17. direkt\u00f6r\u00fc olarak g\u00f6rev yapt\u0131. Bu d\u00f6nemde \u00f6zellikle erken ya\u015fta ortaya \u00e7\u0131kan kanserlerin molek\u00fcler temellerini ve epidemiyolojisini anlamaya y\u00f6nelik Erken Ba\u015flang\u0131\u00e7 Kanser \u0130nisiyatifi\u2019ni hayata ge\u00e7irdi. Bu proje, kanserde ki\u015fiselle\u015ftirilmi\u015f tedavilerin geli\u015ftirilmesinin yan\u0131 s\u0131ra sa\u011fl\u0131k hizmetlerine eri\u015fimdeki e\u015fitsizliklerin giderilmesini ama\u00e7layan giri\u015fimlere ev sahipli\u011fi yapt\u0131. NCI b\u00fcnyesinde olu\u015fturdu\u011fu uzman dan\u0131\u015fma gruplar\u0131, k\u0131rsal ve dezavantajl\u0131 b\u00f6lgelerde kanser bak\u0131m\u0131na y\u00f6nelik sistematik engellerin a\u015f\u0131lmas\u0131 i\u00e7in stratejik \u00f6neriler geli\u015ftirdi.<\/p>\n
Akademik ve klinik alanlardaki \u00fcst\u00fcn ba\u015far\u0131lar\u0131yla tan\u0131nan Dr. Rathmell, NCI\u2019deki ulusal liderli\u011finden \u00f6nce Vanderbilt \u00dcniversitesi T\u0131p Merkezi\u2019nde Hugh Jackson Morgan Endowed T\u0131p Profes\u00f6rl\u00fc\u011f\u00fc yapm\u0131\u015f ve T\u0131p B\u00f6l\u00fcm\u00fc ba\u015fkan\u0131 ile ba\u015fhekim g\u00f6revlerini y\u00fcr\u00fctm\u00fc\u015ft\u00fcr. Buradaki liderli\u011fi s\u0131ras\u0131nda, \u00f6zellikle b\u00f6brek kanseri tedavisinde klinik ara\u015ft\u0131rmalar ile translasyonel ara\u015ft\u0131rmalar\u0131 entegre eden projelere \u00f6nc\u00fcl\u00fck etti. \u00d6nceki g\u00f6rev verdi\u011fi yerlerden biri olan Kuzey Karolina \u00dcniversitesi Chapel Hill\u2019de ise genomik ve fonksiyonel g\u00f6r\u00fcnt\u00fclemenin kullan\u0131ld\u0131\u011f\u0131 ameliyat \u00f6ncesi tedavilerin optimize edilmesi \u00fczerine \u00f6nc\u00fc \u00e7al\u0131\u015fmalar yapt\u0131 ve ki\u015fiselle\u015ftirilmi\u015f onkoloji protokollerinin geli\u015ftirilmesine b\u00fcy\u00fck katk\u0131 sa\u011flad\u0131.<\/p>\n
Dr. Rathmell\u2019in Ohio State\u2019de \u00fcstlenece\u011fi rol yaln\u0131zca y\u00f6netimsel de\u011fil, ayn\u0131 zamanda molek\u00fcler onkoloji, translasyonel t\u0131p ve yenilik\u00e7i klinik bak\u0131m uygulamalar\u0131n\u0131 birle\u015ftiren stratejik bir vizyonun da yans\u0131mas\u0131d\u0131r. Hem James Kanser Hastanesi hem de Kapsaml\u0131 Kanser Merkezi\u2019nin operasyonel liderli\u011fi g\u00f6revini \u00fcstlenerek, ara\u015ft\u0131rma etkisini art\u0131rma ve hasta eri\u015fimini geni\u015fletme konusunda g\u00fc\u00e7l\u00fc ad\u0131mlar atacakt\u0131r. Bu \u00e7ift y\u00f6nl\u00fc sorumluluk, Ohio State\u2019in veri odakl\u0131 klinik yenilik ve toplumsal kat\u0131l\u0131m arac\u0131l\u0131\u011f\u0131yla kanserin morbidite ve mortalitesini azaltma konusundaki kararl\u0131l\u0131\u011f\u0131n\u0131 ortaya koymaktad\u0131r.<\/p>\n
Ataman\u0131n en dikkat \u00e7ekici yanlar\u0131ndan biri, Dr. Rathmell\u2019in Ohio State \u00dcniversitesi\u2019nde \u015fimdiye kadar verilen en y\u00fcksek de\u011ferli ve yeni kurulan Jeri B. Block ve Robert H. Schottenstein Onkoloji Ayr\u0131cal\u0131kl\u0131 K\u00fcrs\u00fcs\u00fc\u2019ne sahip olacak olmas\u0131d\u0131r. 10 milyon dolar de\u011ferindeki bu prestijli k\u00fcrs\u00fc, \u00fcniversitenin kanser ara\u015ft\u0131rmalar\u0131na verdi\u011fi \u00f6nemi somutla\u015ft\u0131rmakta ve Dr. Rathmell\u2019in k\u00fcresel onkoloji arenas\u0131ndaki varl\u0131\u011f\u0131n\u0131 g\u00fc\u00e7lendirme hedefini desteklemektedir.<\/p>\n
Ulusal ve uluslararas\u0131 akademik t\u0131p \u00e7evreleri, Dr. Rathmell\u2019in doktor-ara\u015ft\u0131rmac\u0131 kimli\u011fi ile b\u00f6brek kanseri uzmanl\u0131\u011f\u0131 temelinde liderli\u011fini \u00f6vg\u00fcyle kar\u015f\u0131lamaktad\u0131r. John J. Warner, MD (Ohio State Wexner T\u0131p Merkezi CEO\u2019su) gibi \u00fcst d\u00fczey y\u00f6neticiler, kariyerinin Ohio State\u2019in multidisipliner altyap\u0131s\u0131n\u0131 harekete ge\u00e7irerek \u00f6nemli onkoloji bulu\u015flar\u0131na \u00f6nc\u00fcl\u00fck edece\u011fi de\u011ferlendirmesini yapmaktad\u0131r. Dr. Rathmell\u2019in stratejik vizyonu, temel bilim ke\u015fiflerini klinik uygulamalarla birle\u015ftiren translasyonel ara\u015ft\u0131rmaya g\u00fc\u00e7 verecek, bu sayede malignitelerde tedavi paradigmalar\u0131nda yenilikler sa\u011flanacakt\u0131r.<\/p>\n
Bilimsel katk\u0131lar\u0131nda nefreloji-onkolojiyi kesi\u015ftiren Dr. Rathmell, t\u00fcm\u00f6r biyolojisi ve kanser ilerleyi\u015fini \u015fekillendiren sistemik fakt\u00f6rler konusundaki derin bilgi birikimi ile tan\u0131nmaktad\u0131r. Ulusal T\u0131p Akademisi, Amerikan Sanatlar ve Bilimler Akademisi \u00fcyelikleri ve Amerikan Bilimin \u0130lerlemesine Y\u00f6nelik Dernek\u2019teki (AAAS) fellowship\u2019i bu y\u00fcksek bilimsel etkinli\u011fi teyit etmektedir. Amerikan Kanser Derne\u011fi\u2019nin En Y\u00fcksek Onur Madalyas\u0131 gibi prestijli \u00f6d\u00fcller ise hem bilim hem de hasta bak\u0131m\u0131na olan katk\u0131lar\u0131n\u0131 simgelemektedir.<\/p>\n
Dr. Rathmell\u2019in vizyonunun merkezinde, laboratuvar inovasyonlar\u0131n\u0131n ger\u00e7ek hayat uygulamalar\u0131yla bulu\u015fmas\u0131 vard\u0131r. Klinik \u00e7al\u0131\u015fmalarda genomik veriler ve yeni nesil g\u00f6r\u00fcnt\u00fcleme teknolojilerinin etkin kullan\u0131m\u0131 onun d\u00f6rt temel prensibini olu\u015fturur. Bu yakla\u015f\u0131m, kanser tan\u0131 ve tedavi yan\u0131tlar\u0131n\u0131n hassasiyetini art\u0131r\u0131rken sadece ya\u015fam s\u00fcresini de\u011fil, ayn\u0131 zamanda hastalar\u0131n ya\u015fam kalitesini de iyile\u015ftirmeye odaklan\u0131r. Ki\u015fiselle\u015ftirilmi\u015f onkoloji alan\u0131ndaki bu geli\u015fmeler, modern sa\u011fl\u0131k modellerinin de temel yap\u0131 ta\u015f\u0131d\u0131r.<\/p>\n
Sa\u011fl\u0131k e\u015fitli\u011fi konusundaki g\u00fc\u00e7l\u00fc savunuculu\u011fu, OSUCCC \u2013 James\u2019in misyonuna d\u0131\u015fsal de\u011fil i\u00e7sel bir unsur olarak kazand\u0131r\u0131lmaktad\u0131r. Dr. Rathmell, sosyal sa\u011fl\u0131k belirleyicilerinin kanser ara\u015ft\u0131rmas\u0131 g\u00fcndemine entegre edilmesini sa\u011flayarak, yeniliklerin dezavantajl\u0131 ve k\u0131rsal kesimlere ula\u015fmas\u0131n\u0131 garanti alt\u0131na almay\u0131 ama\u00e7lar. Bu kapsay\u0131c\u0131 yakla\u015f\u0131m, kronikle\u015fen tedavi e\u015fitsizliklerinin \u00fczerine gitmek i\u00e7in kritik \u00f6nem ta\u015f\u0131maktad\u0131r ve b\u00f6ylece sa\u011fl\u0131k hizmetleri daha adil ve eri\u015filebilir hale gelecektir.<\/p>\n
Dr. Rathmell\u2019in kariyer yolu, bilimsel titizlik ve idari liderli\u011fi birle\u015ftiren nadir profillerden biridir. Biophysics alan\u0131nda doktora, Stanford \u00dcniversitesi\u2019nden t\u0131p doktorlu\u011fu, Pennsylvania \u00dcniversitesi\u2019nde t\u0131p ihtisas\u0131 ve Vanderbilt \u00dcniversitesi\u2019nden sa\u011fl\u0131k hizmetleri y\u00f6netimi alan\u0131nda y\u00fcksek lisans gibi karma disiplinler aras\u0131 e\u011fitimleri, karma\u015f\u0131k sa\u011fl\u0131k sistemlerinde etkin y\u00f6netim ve i\u015f birli\u011fi i\u00e7in g\u00fc\u00e7l\u00fc temel olu\u015fturur. Bu donan\u0131m, onu karma\u015f\u0131k sa\u011fl\u0131k ortamlar\u0131nda yenilik\u00e7i translasyonel ara\u015ft\u0131rma ve i\u015f birli\u011fi a\u011flar\u0131n\u0131 geli\u015ftirme y\u00f6n\u00fcnde ideal bir lider yapmaktad\u0131r.<\/p>\n
Ohio State \u00dcniversitesi Kapsaml\u0131 Kanser Merkezi\u2019nin yeni d\u00f6neminde Dr. Rathmell, bilimsel metodolojilerle toplumsal e\u015fitli\u011fi birle\u015ftirip, kanser bak\u0131m\u0131nda uluslararas\u0131 arenada fark yaratmay\u0131 hedeflemektedir. Liderli\u011finde merkezin ara\u015ft\u0131rma portf\u00f6y\u00fcn\u00fcn nitelik ve nicelik olarak artmas\u0131, onkologlar ve biyomedikal bilim insanlar\u0131 i\u00e7in yeni ilham kaynaklar\u0131 yaratmas\u0131 beklenmektedir. Kanser morbiditesi ve mortalitesi \u00fczerindeki etkileri minimize eden yenilik\u00e7i klinik projelerle, Ohio State k\u00fcresel kanser m\u00fccadelesinde \u00f6rnek te\u015fkil edecektir.<\/p>\n
OSUCCC \u2013 James \u00e7at\u0131s\u0131 alt\u0131nda at\u0131lacak ad\u0131mlar, sadece teknoloji ve bilimle de\u011fil, ayn\u0131 zamanda hasta ve halk\u0131n ihtiya\u00e7lar\u0131na cevap verecek e\u015fitlik\u00e7i politikalarla da \u015fekillenecektir. Dr. Rathmell\u2019in saha deneyimi, akademik ge\u00e7mi\u015fi ve federal d\u00fczeydeki y\u00f6neticili\u011fi, onu g\u00fcn\u00fcm\u00fcz\u00fcn zorlu kanser ekosisteminde liderlik g\u00f6revine son derece uygun k\u0131lmaktad\u0131r. Bu atama, Ohio ve \u00f6tesi i\u00e7in kanser ara\u015ft\u0131rmalar\u0131nda yepyeni bir ufuk a\u00e7acakt\u0131r.<\/p>\n
Son olarak, Ohio State kanser merkezi bu liderlikle sadece ulusal de\u011fil, k\u00fcresel boyutta da kanserle m\u00fccadelede \u00f6nc\u00fc rol \u00fcstlenecektir. Dr. Rathmell, bilimden prati\u011fe, ara\u015ft\u0131rmadan topluma k\u00f6pr\u00fc kuran yakla\u015f\u0131m\u0131 ile onkoloji alan\u0131nda d\u00f6n\u00fc\u015f\u00fcm vadediyor. Kanserli hastalar, onlar\u0131n aileleri ve sa\u011fl\u0131k profesyonelleri i\u00e7in \u00fcst d\u00fczey bir umut kayna\u011f\u0131 olacak bu atama, bilimin insan hayat\u0131na yans\u0131mas\u0131n\u0131n somut bir g\u00f6stergesidir.<\/p>\n
—<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Kanser ara\u015ft\u0131rmalar\u0131, B\u00f6brek kanseri, Translasyonel t\u0131p, Sa\u011fl\u0131k e\u015fitli\u011fi Dr. W. Kimryn Rathmell\u2019in The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute\u2019nin (OSUCCC \u2013 James) yeni CEO\u2019su olarak atanmas\u0131, kanser ara\u015ft\u0131rmalar\u0131 ve klinik bak\u0131m alan\u0131nda \u00f6nemli bir d\u00f6nemin ba\u015flang\u0131c\u0131n\u0131 m\u00fcjdeliyor. May\u0131s 2025\u2019te resmi onay\u0131n ard\u0131ndan g\u00f6revine ba\u015flayacak olan Dr. Rathmell, molek\u00fcler biyoloji, onkoloji ve…<\/p>\n","protected":false},"author":1,"featured_media":3663,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[2696,2699,2700,2697,2698],"tmauthors":[],"class_list":{"0":"post-3662","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-dr-w-kimryn-rathmell-ceo-at-ohio-state-cancer-institute","9":"tag-early-onset-cancer-research-and-epidemiology","10":"tag-integration-of-clinical-care-and-cancer-research-strategies","11":"tag-molecular-oncology-and-translational-medicine-leadership","12":"tag-personalized-cancer-treatment-and-health-equity-initiatives"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Rathmell-Ohio-State-Kanser-Enstitusu-CEO8217su-oldu-1745431166.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=3662"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/3662\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/3663"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=3662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=3662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=3662"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=3662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMakale Ba\u015fl\u0131\u011f\u0131<\/strong>: Dr. W. Kimryn Rathmell Takes Helm as CEO of Ohio State\u2019s Comprehensive Cancer Center \u2013 A Vision for Precision Oncology and Health Equity
\nHaberin Yay\u0131n Tarihi<\/strong>: May\u0131s 27, 2025 (g\u00f6reve ba\u015flama tarihi)
\nWeb References<\/strong>: https:\/\/cancer.osu.edu\/, https:\/\/president.osu.edu\/meet-president-carter, https:\/\/wexnermedical.osu.edu\/about-us\/our-people\/john-warner
\nAnahtar Kelimeler<\/strong>: kanser ara\u015ft\u0131rmas\u0131 yenilikleri, sa\u011fl\u0131k hizmetlerinde e\u015fitsizlikler, Erken Ba\u015flang\u0131\u00e7 Kanseri \u0130nisiyatifi, onkolojide sa\u011fl\u0131k e\u015fitli\u011fi, James Kanser Hastanesi liderli\u011fi, molek\u00fcler biyoloji, Ohio State \u00dcniversitesi kanser merkezi, onkoloji liderlik de\u011fi\u015fikli\u011fi, hasta odakl\u0131 kanser bak\u0131m\u0131, Solove Ara\u015ft\u0131rma Enstit\u00fcs\u00fc CEO\u2019su, d\u00f6n\u00fc\u015f\u00fcmc\u00fc kanser ara\u015ft\u0131rmalar\u0131, W. Kimryn Rathmell atamas\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"